Views & Analysis Accelerating clinical research in Brazil Developments that promise to improve clinical research in Brazil.
News NICE green light a win for Lilly in RA market RA drug backed after manufacturer offered discount.
News Kisqali set for approval - but likely to hit same NICE obsta... Concerns that NICE will reject Kisqali like it did Ibrance.
News Gottlieb outlines FDA plan to keep generics cheap Reports also suggest Trump's pricing plans may be pro-industry.
Views & Analysis Immuno-oncology drugs: key to the Cancer Moonshot? Assessing the global challenges inhibiting immuno-oncology market access.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
